News

The solution is expected to support Tigermed’s expansion of operations into Europe and North America. Tigermed chairman and general manager Xiaoping Ye said Tigermed was seeking a CTMS

Oxtellar XR is an antiepileptic drug used as an adjunct therapy to treat partial seizures in adults and in children 6 to 17 years of age. Supernus chief

The C4C project coordinated by CELLforCURE is expected to bring together the skills of two biotech companies, seven public-sector organizations and university medical centers. Five cell therapies are

The drug, FYCOMPA (perampanel), is intended for use as an adjunctive treatment for partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy age 12 and

The study termed as protocol C-400-02 will enroll 75 HSV-2 positive patients to test the efficacy of the HerpV vaccine as measured by effect on genital viral shedding.

The patents include application No.12/702,889 and 13/349,153 for the use of Amarin’s product, Vascepa (icosapent ethyl) capsules, as a treatment for hypertriglyceridemia. Amarin chairman and chief executive officer

Tracking Drugs@FDA and Orange Book Patent Data gives analysis of FDA market intelligence, according to the company. EvaluatePharma research head Anthony Raeside said, "Through our proprietary software platform

Using B-SMART, LabCorp will develop assay that will combine nucleic acid testing with phage-based technology to recognise any resistance of M. tuberculosis clinical isolates to antitubercular antibiotics, irrespective

The grant spread for a year will support research identified by PTC’s proprietary GEMS technology that demonstrates activity against the dengue virus. PTC grant collaborator Eva Harris said,